Dolasetron Oral, Intravenous and Factor VIIa (Recombinant)
Determining the interaction of Dolasetron Oral, Intravenous and Factor VIIa (Recombinant) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dolasetron
Brand name: Anzemet
Synonyms: Dolasetron
Generic Name: coagulation factor viia
Brand name: NovoSeven RT with MixPro, Novoseven, NovoSeven RT
Synonyms: Coagulation factor VIIa (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dolasetron Oral, Intravenous-Factor X (Human)
- Dolasetron Oral, Intravenous-Factor x human Intravenous
- Dolasetron Oral, Intravenous-Factor XIII
- Dolasetron Oral, Intravenous-Factor XIII (Human)
- Dolasetron Oral, Intravenous-Factor XIII A-Subunit (Recombinant)
- Dolasetron Oral, Intravenous-Factor XIII Concentrate (Human)
- Factor VIIa (Recombinant)-Dolasetron Tablets
- Factor VIIa (Recombinant)-Dolgic LQ Oral
- Factor VIIa (Recombinant)-Dolgic Plus
- Factor VIIa (Recombinant)-Dolobid
- Factor VIIa (Recombinant)-Dologen
- Factor VIIa (Recombinant)-Dologesic